Provided by Tiger Trade Technology Pte. Ltd.

CMS Energy Corp

67.08
-0.0700-0.10%
Volume:519.74K
Turnover:35.06M
Market Cap:21.03B
PE:20.14
High:67.80
Open:67.49
Low:67.03
Close:67.15
52wk High:80.36
52wk Low:67.00
Shares:313.58M
Float Shares:311.85M
Volume Ratio:1.22
T/O Rate:0.17%
Dividend:2.23
Dividend Rate:3.32%
EPS(TTM):3.33
EPS(LYR):3.52
ROE:9.16%
ROA:2.97%
PB:2.20
PE(LYR):19.03

Loading ...

CMS Energy Corp : Keybanc Cuts to Sector Weight from Overweight

THOMSON REUTERS
·
Jul 23

KeyBanc Downgrades CMS Energy to Sector Weight From Overweight

MT Newswires Live
·
Jul 23

CMS Energy downgraded to Sector Weight from Overweight at KeyBanc

TIPRANKS
·
Jul 23

CMS Energy Corporation : Wells Fargo Cuts Target Price to $79 from $80

THOMSON REUTERS
·
Jul 22

U.s. Research Roundup-danaher, Gm, Msci

Reuters
·
Jul 22

Earning Preview: CMS Energy Corp this quarter’s revenue is expected to increase by 10.30%, and institutional views are cautious

Earnings Agent
·
Jul 21

CMS Energy Corp. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

CMS Energy Declares Quarterly Cash Dividend of 57 Cents Per Share

Deep News
·
Jul 21

CMS Energy Keeps Quarterly Dividend at $0.57 a Share, Payable Sept. 1 to Holders of Record Aug. 7

MT Newswires Live
·
Jul 21

CMS Energy Declares Quarterly Dividend of 57 Cents a Share

Reuters
·
Jul 21

CMS Energy Corp - Declares Qtrly Dividend of $0.57 Per Share

THOMSON REUTERS
·
Jul 21

CMS Energy's Board of Directors Declares Quarterly Dividend on Common Stock

THOMSON REUTERS
·
Jul 21

Jefferies Adjusts Price Target on CMS Energy to $78 From $74, Maintains Hold Rating

MT Newswires Live
·
Jul 16

CMS Receives Clinical Trial Approval for Its Novel Complement Factor B Inhibitor in Age-Related Macular Degeneration

Stock News
·
Jul 15

Barclays Adjusts CMS Energy Price Target to $81 From $79, Maintains Overweight Rating

MT Newswires Live
·
Jul 14

CMS Energy is Maintained at Overweight by Barclays

Dow Jones
·
Jul 14

CMS Energy Corporation : Barclays Raises Target Price to $81 from $79

THOMSON REUTERS
·
Jul 14

Aroa Biosurgery Says Randomized Controlled Trial for Symphony Product Meets Primary Endpoint

MT Newswires Live
·
Jul 14

Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates

TIPRANKS
·
Jul 14

Arhaus Names Meijer CEO Rick Keyes to Board as Independent Director

Reuters
·
Jul 14